Strategic market and pricing assessment 

We combine strong quantitative skills with strategic and business-oriented thinking to provide comprehensive market potential and pricing assessments

About us

We combine strong quantitative expertise in economic modelling, statistics, and data analytics with a deep understanding of market and pricing dynamics in the life sciences sector. This blend allows us to comprehensively assess the value of new therapies. Our experience covers the development of pharmacoeconomic tools and the integration of these analyses with market and pricing potential assessments. Our goal is to provide tools and strategies that capture clinical and economic value and support successful commercialisation

Lorenzo Celico

Lorenzo is Managing Director of C2 Health Consulting. He specialised in economic evaluation of innovative drug products, and has more than 10 year experience in the healthcare and biotech sector. His expertise includes pharmacoeconomic and budget impact modelling, and financial forecasting. He graduated in Economics from the University of Zurich

Gianluca Furneri

Gianluca is Senior Advisor at C2 Health Consulting. With over 20 years in the healthcare and life sciences sector, he has led more than 50 international pricing and market access projects, building a strong global network of payer expert contacts. He previously founded and led a life sciences consulting boutique before completing a successful exit in 2022

Our services

Market and price potential assessment

We have experience in assessing commercial opportunities and pricing potential for early-stage and late-stage assets, including disease landscape evaluations, patient funnel analysis, and competitive assessment. Our work integrates quantitative forecasting with payer insights to build market potential heatmaps, expected pricing outcomes, and revenue scenarios. This approach enables clients to anticipate key challenges, validate market hypotheses, and optimize development and P&R strategies

Economic models and analytics

We have experience in developing health economic models, ranging from cost-minimization and budget impact analyses to more sophisticated cost-effectiveness models

We also have extensive experience in performing various types of advanced statistical analyses of clinical trial data, ranging from Indirect Treatment Comparisons to longitudinal and survival analyses

Value communication

We have experience writing value stories and Global Value Dossier (GVD) that support market access activities. Thanks to a solid understanding of the market access dynamics, we know how to effectively communicate the value of a new product to payers and decision-makers

Our strengths

Focus on successful P&R process

Our ultimate goal is to create tools that provide a strong basis for the P&R negotiations and lead to a positive reimbursement recommendation in the target countries

Solid quantitative knowledge blended with business-oriented thinking

We both have a strong understanding of pharmacoeconomics and knowledge of the market access dynamics

Large network of payer experts

We have long-standing collaborations with multiple payer experts in Europe and the US. This garantees  access to a broad range of expertise

Contact

c2.health.consulting@gmail.com

+41 79 892 41 90

Vorderbergstrasse 24, 6318 Walchwil (ZG), Switzerland